−4.15PLN
−92.11 MPLN
46.86 MPLN
18.64 M
About RYVU
Sector
CEO
Pawel Przewiezlikowski
Headquarters
Kraków
Website
Founded
2007
ISIN
PLSELVT00013
FIGI
BBG001VBZ2F9
Ryvu Therapeutics SA engages in the provision of products and solutions for the pharmaceutical and biotechnology industry. Its projects and services include contract chemistry services, biology services, integrated drug discovery, and comparative studies of biosimilar medicinal products. The company was founded by Boguslaw Sieczkowski and Pawel Przewiezlikowski in 2007 and is headquartered in Krakow, Poland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RVU is 43.90 PLN — it has decreased by −2.01% in the past 24 hours. Watch RYVU stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange RYVU stocks are traded under the ticker RVU.
RVU stock has fallen by −10.77% compared to the previous week, the month change is a −16.22% fall, over the last year RYVU has showed a −22.16% decrease.
We've gathered analysts' opinions on RYVU future price: according to them, RVU price has a max estimate of 80.00 PLN and a min estimate of 67.00 PLN. Watch RVU chart and read a more detailed RYVU stock forecast: see what analysts think of RYVU and suggest that you do with its stocks.
RVU stock is 7.27% volatile and has beta coefficient of 0.20. Track RYVU stock price on the chart and check out the list of the most volatile stocks — is RYVU there?
Today RYVU has the market capitalization of 1.04 B, it has decreased by −5.40% over the last week.
Yes, you can track RYVU financials in yearly and quarterly reports right on TradingView.
RYVU revenue for the last quarter amounts to 23.00 M PLN, despite the estimated figure of 21.90 M PLN. In the next quarter, revenue is expected to reach 23.00 M PLN.
RVU net income for the last quarter is −30.42 M PLN, while the quarter before that showed −19.40 M PLN of net income which accounts for −56.81% change. Track more RYVU financial stats to get the full picture.
No, RVU doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 276.00 employees. See our rating of the largest employees — is RYVU on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RYVU EBITDA is −115.99 M PLN, and current EBITDA margin is −228.79%. See more stats in RYVU financial statements.
Like other stocks, RVU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RYVU stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RYVU technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RYVU stock shows the sell signal. See more of RYVU technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.